SLDX Stock Chart & Stats
$0.01
$0.00(0.00%)
At close: 4:00 PM EDT
$0.01
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.01 - $0.05
Previous CloseN/A
Volume20.00
Average Volume (3M)1.09K
Market Cap
$2.43M
Enterprise Value$13.43M
Total Cash (Recent Filing)$32.22K
Total Debt (Recent Filing)$3.99M
Price to Earnings (P/E)―
Beta-1.48
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding301,505,430
10 Day Avg. Volume0
30 Day Avg. Volume1,090
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)-0.20
Price to Sales (P/S)3.00
P/FCF Ratio-4.12
Enterprise Value/Market Cap5.53
Enterprise Value/Revenue7.63
Enterprise Value/Gross Profit-22.13
Enterprise Value/Ebitda-3.43
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
SLDX FAQ
What was Stella Diagnostics’s price range in the past 12 months?
Stella Diagnostics lowest stock price was $0.01 and its highest was $0.05 in the past 12 months.
What is Stella Diagnostics’s market cap?
Stella Diagnostics’s market cap is $2.43M.
When is Stella Diagnostics’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Stella Diagnostics’s earnings last quarter?
Currently, no data Available
Is Stella Diagnostics overvalued?
According to Wall Street analysts Stella Diagnostics’s price is currently Overvalued.
Does Stella Diagnostics pay dividends?
Stella Diagnostics does not currently pay dividends.
What is Stella Diagnostics’s EPS estimate?
Stella Diagnostics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Stella Diagnostics have?
Stella Diagnostics has 301,505,430 shares outstanding.
What happened to Stella Diagnostics’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Stella Diagnostics?
Currently, no hedge funds are holding shares in SLDX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Stella Diagnostics
Stella Diagnostics Inc. is a molecular diagnostics firm primarily focused on advancing patient care strategies for individuals afflicted with severe esophageal disorders. The company's specialized clinical tests furnish physicians with crucial information regarding the molecular makeup of a patient's tissue, enabling them to ascertain if the disease is static, deteriorating, or undergoing malignant transformation. Additionally, Stella Diagnostics is engaged in the development of innovative diagnostic tools intended to provide healthcare professionals with enhanced molecular insights compared to conventional screening methods. The organization rebranded from its previous identity, JMP Properties, Inc., to Stella Diagnostics, Inc. in April 2021 and is based in Salt Lake City, Utah.